Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for Our Annual Action for Impact Summit!
WBC’s Annual Action for Impact Summit unites thousands of attendees on a fully interactive platform, enabling participants to network, connect, and exchange ideas, innovations, and impact in real time.
WOMEN CEO REPORT
Mina Kim is the CEO of Acelyrin, Inc., a biopharmaceutical company focused on developing innovative therapies for complex and underserved medical conditions. Kims leadership is marked by a commitment to advancing drug development and improving patient outcomes through cutting-edge research. With a strong background in biotechnology and strategic management, she has been instrumental in guiding Acelyrin through crucial stages of clinical development and market preparation. Her vision includes leveraging advanced science and technology to address significant health challenges. Under her guidance, Acelyrin continues to make progress in developing transformative therapies and advancing its mission in the biopharmaceutical field.
